AWARD
A -- Nationwide Expanded Access Program (EAP) to facilitate the use of human convalescent plasma to treat hospitalized coronavirus-2 (SARS-CoV-2) COVID-19 patients
- Notice Date
- 5/1/2020 12:49:35 PM
- Notice Type
- Award Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- ASPR OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Washington DC 20201 USA
- ZIP Code
- 20201
- Solicitation Number
- 75A50120C00096
- Archive Date
- 05/16/2020
- Point of Contact
- Jeffrey Schmidt, Phone: 2022050260
- E-Mail Address
-
jeffrey.schmidt2@hhs.gov
(jeffrey.schmidt2@hhs.gov)
- Award Number
- 75A50120C00096
- Award Date
- 05/01/2020
- Awardee
- MAYO CLINIC Rochester MN USA
- Award Amount
- 48927887.00
- Description
- The overall goal of the proposed work is to support a nationwide Expanded Access Program (EAP) to facilitate the use of human convalescent plasma to treat hospitalized coronavirus-2 (SARS-CoV-2) COVID-19 patients. The overarching goal of this project is develop a set of tools that physicians at the bedside can use to administer COVID-19 convalescent plasma to hospitalized COVID-19 patients to increase the survival rate. These tools will be largely web based and include: (1) Comprehensive background information including key administrative and clinical workflows; (2) Robust user support staffed by high-level, content experts via direct calls with physician and nurse navigators, a call center, and dedicated email address; (3) Simple and compliant enrollment documentation for institutions, physicians, and patients; (4) Centralized regulatory and ethical support via central IRB and DSMB; (5) Information and forms about how to consent patients in a safe and compliant manner; (6) Case report forms for timely data reporting; (7) Infrastructure for comprehensive, program-wide data analysis and broad-based reporting of results; (8) Biobank� apabilities for retrospective analysis of convalescent plasma samples to determine how factors like antibody titers� related to changes in patient outcomes; and (9) Modest financial support for each patient enrolled.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/ffa37167afcf4ae5bf753441a22db5b3/view)
- Record
- SN05642116-F 20200503/200501230136 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |